Rockwell Medical Announces FDA Advisory Committee Review Of Triferic For The Treatment Of Iron Replacement And Maintenance Of Hemoglobin In Hemodialysis Patients
October 09, 2014 at 07:31 AM EDT
Rockwell Medical, Inc. (Nasdaq: RMTI), a fully integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic ...
